John F. DiPersio, MD

• Acute Myeloid Leukemia

Dr. John F. DiPersio, Deputy Director, Alvin J. Siteman Cancer Center and Chief of the Division of Oncology at Washington University School of Medicine in St. Louis and the Virginia E. and Samuel J. Golman Professor of Medicine.

Dr. DiPersio’s research focuses on fundamental and translational aspects of leukemia and stem cell biology. These studies include identification of genetic abnormalities in human leukemias, understanding processes involving stem cell and leukemia cell trafficking, and clinical and translational programs in both leukemia/myelodysplastic syndrome and transplantation immunology.

Among his many accomplishments, Dr. DiPersio was instrumental in developing a drug called plerixafor and ruxolitnib in 2019 that were approved by the U.S. Food and Drug Administration in 2008 and 2019 respectively for the treatment of multiple myeloma, non-Hodgkin’s lymphoma and graft versus host disease.